duration of endocrine therapy in early breast cancer
Published 1 year ago • 164 plays • Length 0:35Download video MP4
Download video MP3
Similar videos
-
0:42
role of endocrine therapy in early-stage hr-positive breast cancer
-
4:01
duration of endocrine therapy in breast cancer
-
6:09
adjuvant endocrine therapy for breast cancer: optimal durations and regimens
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
8:18
endocrine therapy in premenopausal women with hr breast cancer
-
1:38
unanswered questions in the use of adjuvant therapy in early breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
4:02
assessment of short preoperative endocrine therapy in the adapt and adaptcycle trials
-
1:00
therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancer
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
4:37
predict underestimates survival of patients with her2 early breast cancer
-
1:30
exploring endocrine therapy innovations for high-risk hormone receptor-positive breast cancer
-
1:11
endocrine therapy treatment radiosensitizes er breast cancer